Navigation Links
Endologix to Present at Two Upcoming Conferences
Date:8/3/2011

IRVINE, Calif., Aug. 3, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences.  The first presentation will be at the 31st Annual Canaccord Genuity Growth Conference in Boston, MA.   Event:31st Annual Canaccord Genuity Growth Conference   Date:Thursday, August 11, 2011   Time:10:00 a.m. ETThe second presentation will be at Wedbush Securities 2011 Life Sciences Management Access Conference in New York.

  Event:Wedbush Securities 2011 Life Sciences Management Access Conference   Date:Tuesday, August 16, 2011   Time:1:50 p.m. ETAn audio Web cast of the Company's presentations will be available by visiting the investor relations section of Endologix's Web site at www.endologix.com.  A replay of the presentations will be available for 30 days.

About Endologix, Inc.Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S.  The Nellix® Endovascular System and Ventana™ Fenestrated Stent Graft System are investigational devices.  Additional information can be found on Endologix's Web site at www.endologix.com. COMPANY CONTACT:

INVESTOR CONTACTS:Endologix, Inc.

The Ruth GroupJohn McDermott, CEO

Nick Laudico (646) 536-7030(949) 595-7200

Zack Kubow (646) 536-7020www.endologix.com
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endologix Reports 22% Second Quarter 2011 Revenue Growth
2. Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products
3. Endologix to Report Second Quarter 2011 Financial Results on July 21, 2011
4. Endologix Announces FDA Approval of AFX™ Endovascular AAA System
5. Endologix to Present at the 2011 Bank of America Merrill Lynch Health Care Conference
6. Endologix Files Form 10-K; Nellix Purchase Price Allocation Finalized
7. Endologix to Present at the ROTH 23rd Annual OC Growth Stock Conference
8. Endologix Reports 41% Fourth Quarter 2010 Revenue Growth
9. Endologix Announces Presentation of Favorable Initial PEVAR Trial Results
10. Endologix Announces Favorable Clinical Results for Nellix Technology
11. Endologix to Report Fourth Quarter and Full Year 2010 Financial Results on February 22, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... , April 26, 2017 Phoenix Marketing Solutions ( ... year of fulfilling its mission of transforming science into clinical ... scrutinized, Phoenix,s innovative approach supports the ... about the latest advances in science and medicine — which ... was founded in 2002 by Tracy Doyle ...
(Date:4/25/2017)... International plc (NASDAQ: ENDP ) will announce its first-quarter ... team will host a conference call and webcast before the U.S. ... dial-in number to access the call is U.S./ Canada ... Please dial in 10 minutes prior to the scheduled start time. ... will be available from May 9, 2017 at 11:30 a.m. ET ...
(Date:4/24/2017)... UNION CITY, Calif. , April 24, 2017 /PRNewswire/ ... providing durability, grip, protection, and comfort, announces the release ... the Powerform S8+. This most recent example of leading ... high density grip pattern for 200% more tactile grip ... in user protection and durability. With TracTek and a ...
Breaking Medicine Technology:
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Plastic Surgery ... , have been asked to present at the upcoming Aesthetic Meeting. Held in San ... 27-May 2. Drs. Furnas and Canales will lend their expertise to the Premier Global ...
(Date:4/26/2017)... ... April 26, 2017 , ... CareSet Labs ... of e-prescribing as measured in Part D Medicare data. The dataset, called PaPR ... either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") data set ...
(Date:4/26/2017)... ... , ... Miami native and local periodontist Dr. John Paul Gallardo ... back in 1991 that this journey would have taken me into so many learning ... Dr. Gallardo has pioneered implant dentistry innovation, evolving into an internationally recognized leader in ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a ... announce that it has received 510(k) clearance from the U.S. Food & Drug ... MyoCycle Pro. , Both devices are stationary cycling systems that use MYOLYN’s patent-pending ...
(Date:4/25/2017)... ... 25, 2017 , ... A stressful work environment can hurt the physical and ... and performance in the workplace. The goal of Clearview Resolution Services has always been ... April, Clearview Resolution Services will be shutting down the office early on Fridays. The ...
Breaking Medicine News(10 mins):